Celerity Lifescience And Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 29-05-2024
- Paid Up Capital ₹ 0.10 M
as on 29-05-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2020)
- Profit -418.82%
(FY 2020)
- Ebitda -716.86%
(FY 2020)
- Net Worth -488.83%
(FY 2020)
- Total Assets -26.54%
(FY 2020)
About Celerity Lifescience And Healthcare
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Khobragade, Gaurav Sharma, Rahul Zade, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999PN2018PTC178581
- Company No.
178581
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2018
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Celerity Lifescience And Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Khobragade  | Managing Director | 07-Sep-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaurav Sharma | Director | 17-Jul-2019 | Current |
| Rahul Zade | Director | 01-Jul-2019 | Current |
| Mangesh Dhule | Director | Current |
Financial of Celerity Lifescience And Healthcare.
Celerity Lifescience And Healthcare Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 418.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 488.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Celerity Lifescience And Healthcare?
Unlock access to Celerity Lifescience And Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- D-Art Hospitals And Research Institute Private LimitedActive 5 years 10 months
Mangesh Dhule is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Celerity Lifescience And Healthcare?
Unlock and access historical data on people associated with Celerity Lifescience And Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Celerity Lifescience And Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Celerity Lifescience And Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
